ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GLAXF GSK Plc (PK)

18.06
-0.26 (-1.42%)
Last Updated: 16:45:17
Delayed by 15 minutes
Share Name Share Symbol Market Type
GSK Plc (PK) USOTC:GLAXF OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.26 -1.42% 18.06 18.00 19.00 18.67 18.00 18.00 4,294 16:45:17

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

20/08/2024 3:42pm

Edgar (US Regulatory)


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
For the month of August 2024
 
Commission File Number 001-15170
 
 
GSK plc
(Translation of registrant's name into English)
 
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive office)
 
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
 
 
 
GSK plc (the 'Company')
 
Transaction notification
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Dr Hal Barron
 
b)
Position/status
Non-Executive Director
 
c)
Initial notification/ amendment

Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Acquisition of notional ADSs within Dr Barron's GSK Executive Supplemental Savings Plan account following the reinvestment of dividends
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
 
$41.2800
2,735.162
 
 
 
 
 
 
d)
Aggregated information
 
N/A (single transaction)
Aggregated volume
Price
 
 
e)
Date of the transaction
2024-08-16
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
James Ford
 
b)
Position/status
SVP and Group General Counsel, Legal and Compliance
 
c)
Initial notification/ amendment

Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Acquisition of notional ADSs within Mr Ford's GSK Executive Supplemental Savings Plan account following the reinvestment of dividends
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
 
$41.2800
50.895
 
 
 
 
 
 
d)
Aggregated information
N/A (single transaction)
 
Aggregated volume
Price
 
 
e)
Date of the transaction
2024-08-16
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Dr Hal Barron
 
b)
Position/status
Non-Executive Director
 
c)
Initial notification/ amendment

Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Acquisition of ADSs within Dr Barron's GSK 401(k) plan account following the reinvestment of dividends
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
 
$41.2800
69
 
 
 
 
 
 
d)
Aggregated information
 
N/A (single transaction)
Aggregated volume
Price
 
 
 
e)
Date of the transaction
2024-08-16
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
 
 
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
GSK plc
 
(Registrant)
 
 
Date: August 20, 2024
 
 
 
 
By:/s/ VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GSK plc

1 Year GSK (PK) Chart

1 Year GSK (PK) Chart

1 Month GSK (PK) Chart

1 Month GSK (PK) Chart